PARIS, March 09, 2026 (GLOBE NEWSWIRE) -- kyron.bio, a biotechnology company pioneering precision glycoengineering for antibody therapeutic ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Aberrant Glycosylation Drives Kidney Disease Pathogenesis. This schematic illustrates how abnormal glycosylation contributes to diverse kidney diseases: (A) galactose-deficient IgA1 in ...

Scientists from Croatia have identified 90 genes associated with the glycosylation of immunoglobulin (IgG). The team, who has already shown that 20 of these genes can be used to tweak glycosylation ...

Therapeutic antibodies are among the most widely used biologic medicines, yet detecting subtle structural differences in these complex proteins remains challenging. Researchers in Japan have ...

Kidney diseases affect nearly 700 million people worldwide and are a growing cause of mortality and health care costs. Chronic kidney disease (CKD) alone contributes to over 1.2 million deaths ...

Research captures how the GRP94 protein shields itself to make sure it forms properly and suggests a way to target it for future disease treatments. Proteins are often called the building blocks of ...

A comprehensive study mapped the dynamic glycosylation landscape of rat serum proteins, uncovering sex- and time-dependent variations with clear cell-type specificity. Researchers found distinct ...

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...